Effect of Xiangdan Injection in Treating Acute Coronary Syndrome and Inflammatory Markers
- VernacularTitle:香丹注射液治疗急性冠脉综合征的临床研究及其对炎症指标的影响
- Author:
Yongdun HONG
;
Hui WU
;
Honghui MO
;
Feiyuan LI
- Publication Type:Journal Article
- Keywords:
Xiangdan Injection;
acute coronary syndrome;
TCD therapy;
C-reactive protein;
interleukin-6;
tumor necrosis factor-?
- From:
Traditional Chinese Drug Research & Clinical Pharmacology
2000;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the relationship between acute coronary syndrome(ACS) and inflammation , and to observe the short-term effect of Xiangdan Injection(XI) in treating ACS and on inflammatory markers.Methods One hundred and twenty cases of ACS were randomized into two groups: 90 cases in treatment group and 30 in control group. All of the patients received the routine treatment, and the treatment group treated with XI additionally. The therapeutic effect was observed and plasma contents of inflammatory markers such as C-reactive protein (CRP), interleukin 6 (IL-6) and tumor necrosis factor ?(TNF-?) were detected before and after treatment.Results The effect of treatment group was better than that of the control group(P
